Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis.

Honda, Hirokazu; Tanaka, Kenji; Michihata, Tetsuo; Shibagaki, Keigo; Yuza, Toshitaka; Hirao, Keiichi; Tomosugi, Naohisa; Ganz, Tomas; Higashimoto, Yuichiro

Honda, Hirokazu; Tanaka, Kenji; Michihata, Tetsuo; Shibagaki, Keigo; Yuza, Toshitaka; Hirao, Keiichi; Tomosugi, Naohisa; Ganz, Tomas; Higashimoto, Yuichiro.

Afiliação

Honda H; Department of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Tanaka K; Division of Dialysis, Suiyukai Clinic, Nara, Japan.
Michihata T; Division of Dialysis, Ebara Clinic, Tokyo, Japan.
Shibagaki K; Division of Dialysis, Shibagaki Dialysis Clinic Jiyugaoka, Tokyo, Japan.
Yuza T; Division of Dialysis, Shibagaki Dialysis Clinic Kugahara, Tokyo, Japan.
Hirao K; Division of Dialysis, Shibagaki Dialysis Clinic Togoshi, Tokyo, Japan.
Tomosugi N; Division of Systems Bioscience for Drug Discovery, Medical Research Institute, Kanazawa Medical University, Kanazawa, Japan.
Ganz T; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Higashimoto Y; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Clin Kidney J ; 14(3): 943-949, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33777378

Palavras-chave

erythroferrone; erythropoiesis; hepcidin 25; iron metabolism; phosphate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Kidney J Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google